Amedeo Smart

Free Medical Literature Service


 

Amedeo

Obesity

  Free Subscription

Articles published in
Diabetes Metab
    December 2023
  1. KOUIDRAT Y, Collen LL, Vaxillaire M, Dechaume A, et al
    Dominant PDX1 deficiency causes highly penetrant diabetes at different ages, associated with obesity and exocrine pancreatic deficiency: lessons for precision medicine.
    Diabetes Metab. 2023 Dec 21:101507. doi: 10.1016/j.diabet.2023.101507.
    >> Share

    November 2023
  2. LAFARGE JC, Aron-Wisnewsky J, Pattou F, Cucherat M, et al
    French National Authority for Health assessment of metabolic surgery for type 2 diabetes remission- a meta-analysis in patients with class I to III obesity.
    Diabetes Metab. 2023 Nov 22:101495. doi: 10.1016/j.diabet.2023.101495.
    >> Share

    May 2023
  3. YANG Z, Shen P, Qu Y, Xu L, et al
    Baseline and longitudinal trajectories of body-mass index and all-cause mortality among patients with type 2 diabetes.
    Diabetes Metab. 2023;49:101426.
    >> Share

    March 2023
  4. AMADOU C, Heude B, de Lauzon-Guillain B, Lioret S, et al
    Early origins of metabolic and overall health in young adults: An outcome-wide analysis in a general cohort population.
    Diabetes Metab. 2023;49:101414.
    >> Share

    July 2022
  5. RIVIERE B, Jaussent A, Macioce V, Faure S, et al
    The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients.
    Diabetes Metab. 2022;48:101345.
    >> Share

    June 2022
  6. VALENZUELA-VALLEJO L, Chrysafi P, Mantzoros CS
    Liraglutide-induced effects on energy intake and glycemic profile are independent of total and intact GDF-15 levels in subjects with obesity and diabetes.
    Diabetes Metab. 2022 Jun 28:101369. doi: 10.1016/j.diabet.2022.101369.
    >> Share

  7. LEMBO E, Russo MF, Verrastro O, Anello D, et al
    Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes.
    Diabetes Metab. 2022 Jun 24:101363. doi: 10.1016/j.diabet.2022.101363.
    >> Share

    May 2022
  8. XI Y, Gao W, Zheng K, Lv J, et al
    Overweight and risk of type 2 diabetes: A prospective Chinese twin study.
    Diabetes Metab. 2022;48:101278.
    >> Share

    January 2022
  9. KUMAR S, Khatri M
    Response to "A high lean body mass is not protecting from type 2 diabetes in the presence of a high body fat mass".
    Diabetes Metab. 2022;48:101302.
    >> Share

  10. MORICONI D, Manca ML, Anselmino M, Rebelos E, et al
    Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study.
    Diabetes Metab. 2022;48:101282.
    >> Share

  11. BI J, Song L, Wang L, Su B, et al
    Transitions in metabolic health status over time and risk of heart failure: A prospective study.
    Diabetes Metab. 2022;48:101266.
    >> Share

    November 2021
  12. BREDER I, Wolf VLW, Soares AAS, de Carvalho LSF, et al
    Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: an active-controlled randomised trial.
    Diabetes Metab. 2021 Nov 19:101304. doi: 10.1016/j.diabet.2021.101304.
    >> Share

    March 2021
  13. PRANATA R, Lim MA, Yonas E, Vania R, et al
    Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis.
    Diabetes Metab. 2021;47:101178.
    >> Share

  14. LEON-MIMILA P, Villamil-Ramirez H, Li XS, Shih DM, et al
    Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes.
    Diabetes Metab. 2021;47:101183.
    >> Share

  15. LI F, Duan J, Yang Y, Yan G, et al
    Distinct uric acid trajectories are associated with incident diabetes in an overweight Chinese population.
    Diabetes Metab. 2021;47:101175.
    >> Share

    September 2020
  16. MONNIER L, Schlienger JL, Colette C, Bonnet F, et al
    The obesity treatment dilemma: Why dieting is both the answer and the problem? A mechanistic overview.
    Diabetes Metab. 2020 Sep 28. pii: S1262-3636(20)30127.
    >> Share

    February 2020
  17. BOTHOU C, Beuschlein F, Spyroglou A
    Links between aldosterone excess and metabolic complications: A comprehensive review.
    Diabetes Metab. 2020;46:1-7.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016